Meta Biomed Co., Ltd. (KOSDAQ: 059210)

Market Cap	94.46B
Revenue (ttm)	92.30B
Net Income (ttm)	15.34B
Shares Out	22.87M
EPS (ttm)	405.80
PE Ratio	10.28
Forward PE	n/a
Dividend	20.00 (0.51%)
Ex-Dividend Date	Dec 27, 2023

Volume	216,780
Average Volume	168,822
Open	4,130.00
Previous Close	4,130.00
Day's Range	4,090.00 - 4,175.00
52-Week Range	3,210.00 - 5,570.00
Beta	0.68
RSI	67.37
Earnings Date	Mar 20, 2025

About Meta Biomed

Meta Biomed Co., Ltd. engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. The company's dental products include endodontics, dental equipment, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products; suture materials, such as functional and orthopedic suture materials; biomaterials, that includes polymer, multifilament yarn, 3D printing filaments, and bioceramic powder; and aux...

• Industry: Dental Equipment and Supplies
• Founded: 1990
• Employees: 271
• Stock Exchange: KOSDAQ
• Ticker Symbol: 059210

Financial Performance

In 2023, Meta Biomed's revenue was 83.10 billion, an increase of 20.54% compared to the previous year's 68.94 billion. Earnings were 10.08 billion, an increase of 283.61%.